Zobrazeno 81 - 90
of 293
pro vyhledávání: '"Jane S Hankins"'
Autor:
Jane S. Hankins, Nirmish Shah
Publikováno v:
The Lancet. Haematology. 7(10)
Autor:
Jane S. Hankins, Jeffrey Glassberg, Liliana Preiss, Julie Kanter, Paula Tanabe, Kimberly Souffront, Lynne D. Richardsona, Lewis L. Hsu, Robert W. Gibson, Allison A. King, Elizabeth A. Linton, Dania A. Goodin, Jena Simon
Publikováno v:
Ann Emerg Med
Study objective Guided by an implementation science framework, this needs assessment identifies institutional-, provider-, and patient-level barriers to care of sickle cell disease (SCD) in the emergency department (ED) to inform future interventions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ae9ed098a0e7e7d09fd95f11b6be18c
https://europepmc.org/articles/PMC7511000/
https://europepmc.org/articles/PMC7511000/
Autor:
Donald Brambilla, Lisa DiMartino, Lisa M. Klesges, Chinonyelum Nwosu, Abdullah Kutlar, Nirmish Shah, Sherif M. Badawy, Theresa DeMartino, Jane S. Hankins, Ebony Burns, Hamda Khan, Sara Jacobs, Ana A. Baumann
Publikováno v:
Blood
Background: Sickle cell disease (SCD) is a chronic blood disorder, which disproportionately impacts Black individuals. Hydroxyurea therapy prevents SCD-related complications; yet it is underutilized, which contributes to further health inequities. Mo
Autor:
Gregory T. Armstrong, Zhaoming Wang, Daniel A. Mulrooney, Yutaka Yasui, Jeremie H. Estepp, Carmen L. Wilson, Parul Rai, Yadav Sapkota, Melissa M. Hudson, John L. Jefferies, Matthew J. Ehrhardt, Leslie L. Robison, Yan Chen, Na Qin, Jinghui Zhang, Jane S. Hankins, Paul W. Burridge
Publikováno v:
Cancer Res
Cardiomyopathy occurs at significantly higher rates in survivors of childhood cancer than the general population, but few studies have evaluated racial or ethnic disparities, and none have assessed potential genetic factors contributing to this outco
Autor:
Jeffrey A. Glassberg, Elizabeth A. Linton, Katrina Burson, Tabitha Hendershot, Joseph Telfair, Julie Kanter, Victor R. Gordeuk, Allison A. King, Cathy L. Melvin, Nirmish Shah, Jane S. Hankins, Axel Yannick Epié, Lynne D. Richardson, for the Sickle Cell Disease Implementation Consortium
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-6 (2020)
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-6 (2020)
Background Sickle cell disease (SCD) is an autosomal recessive blood disorder affecting approximately 100,000 Americans and 3.1 million people globally. The scarcity of relevant knowledge and experience with rare diseases creates a unique need for co
Autor:
Theodore Wun, Cathy L. Melvin, Lisa DiMartino, Cecelia Calhoun, Marsha Treadwell, Nirmish Shah, Ana A. Baumann, Victor R. Gordeuk, Robert W. Gibson, Donald Brambilla, Michael B. Potter, Jane S. Hankins, Jena Simon, Hayden B. Bosworth, Richard Lottenberg, Abdullah Kutlar, Maria E. Fernandez, Lisa M. Klesges
Publikováno v:
JMIR Research Protocols, Vol 9, Iss 7, p e16319 (2020)
JMIR Research Protocols
JMIR Research Protocols
Background Hydroxyurea prevents disease complications among patients with sickle cell disease (SCD). Although its efficacy has been endorsed by the National Health Lung and Blood Institute evidence-based guidelines, its adoption is low, both by patie
Publikováno v:
Viral Immunol
When an individual is exposed to a viral pathogen for the first time, the adaptive immune system is naive and cannot prevent virus replication. The consequence may be severe disease. At the same time, the host may rapidly generate a pathogen-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a445dca069ed280cbce7a091566992e2
https://europepmc.org/articles/PMC7247049/
https://europepmc.org/articles/PMC7247049/
Autor:
Matthew P. Smeltzer, L. Ashley Robinson, Kristen E. Howell, Jane S. Hankins, James G. Gurney, Meghan Meadows-Taylor, Jeremie H. Estepp, Vikki G. Nolan, Winfred C. Wang, Joacy G. Mathias
Publikováno v:
EJHaem. 1(1)
Due to fear of short-term toxicities, there is nonconsensus of hydroxycarbamide dosing strategy (escalated vs fixed-dosing methods), which contributes to its suboptimal use. We performed a meta-analysis to summarize the incidence rates of toxicities
Autor:
Jerlym S. Porter, Kristoffer S. Berlin, Jane S. Hankins, Jeanelle S. Ali, Frank Andrasik, Jane E. Schreiber, Sheila Anderson
Publikováno v:
British Journal of Haematology. 189
Autor:
Sarah Norell, Marsha Treadwell, Cecelia Calhoun, Lingzi Luo, Shannon Phillips, Lucia Rojas Smith, Sherif M. Badawy, Hamda Khan, Jerlym S. Porter, Paula Tanabe, Chinonyelum Nwosu, Jason R. Hodges, Jane S. Hankins, Allison A. King
Publikováno v:
Blood Adv
Blood advances, vol 4, iss 18
Blood advances, vol 4, iss 18
Hydroxyurea is an efficacious treatment for sickle cell disease (SCD), but adoption is low among individuals with SCD. The objective of this study was to examine barriers to patients’ adherence to hydroxyurea use regimens by using the intentional a